Tammera buys RRMS 47.68: Québec to fund treatment with AUBAGIO⢠for Relapsing Remitting Multiple Sclerosis
AUBAGIO is used as monotherapy for the treatment of RRMS to reduce the frequency of clinical exacerbations ... Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). ...
45 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home